Iovance Biotherapeutics
Price & Volume
Stats
See moreOpen | $2.14 |
Previous Close | $2.10 |
Day Range | $2.09-$2.16 |
52W Range | $1.64-$12.51 |
Market Cap | $759.8M |
Shares Short | 72M |
Financials
See moreRevenue (12 Mos) | $241.5M |
Revenue Growth (YoY) | 92.7% |
Gross Profit (12 Mos) | $49.7M |
Diluted EPS | -$1.21 |
News
See moreYahoo Finance • 11 hours ago
Is Iovance Biotherapeutics Stock Your Ticket to Becoming a Millionaire?
Yahoo Finance • 5 days ago
IOVANCE (IOVA) ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Iovance Biotherapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 19 days ago
Shares of WOR Now Oversold
Yahoo Finance • 24 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 838 |
